CROHN'S DISEASE - ADALIMUMAB AND INFLIXIMAB

NICE Appraisal

TA187  Use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab, and infliximab [review]) for Crohn's disease (review of TA40) (May 2010)

 

DSU Reports

DSU response to comments on DSU Crohn's Report 2 (August 2009)

Use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab and infliximab) for Crohn's Disease - Report 2 (June 2009)

Use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab and infliximab) for Crohn's Disease (January 2009)

 

To receive notification when new reports or documents are uploaded to this website, please join our mailing list by entering your details on the right of this page or follow us on Twitter @NICE_DSU